Pelthos Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	31.98	17.97	0.51	0.1	0.06	-
Cash & Short-Term Investments	31.98	17.97	0.51	0.1	0.06	-
Cash Growth	24250.24%	3403.51%	432.21%	75.02%	-	-
Receivables	11.7	8.86	-	-	-	-
Inventory	23.42	23.57	-	-	-	-
Prepaid Expenses	2.46	1.21	-	-	-	-
Restricted Cash	0.25	0.05	-	-	-	-
Other Current Assets	-	1.75	0.86	-	-	-
Total Current Assets	69.8	53.41	1.37	0.1	0.06	-
Property, Plant & Equipment	12.46	12.84	-	-	-	-
Goodwill	24.68	24.68	-	-	-	-
Other Intangible Assets	38.44	39.47	-	-	-	-
Total Assets	145.38	130.4	1.37	0.1	0.06	-
Accounts Payable	6.15	2.99	1.9	4.62	2.99	2.58
Accrued Expenses	12.84	15.36	-	0.65	0.22	-
Short-Term Debt	-	-	2.19	1.27	0.54	-
Current Portion of Leases	0.64	0.64	-	-	-	-
Current Unearned Revenue	0.98	0.97	-	-	-	-
Other Current Liabilities	4.4	6.04	-	0.01	0.01	-
Total Current Liabilities	25	25.99	4.08	6.54	3.76	2.58
Long-Term Debt	49.64	31.44	-	-	-	1.1
Long-Term Leases	2.65	2.75	-	-	-	-
Long-Term Unearned Revenue	1.03	1.28	-	-	-	-
Other Long-Term Liabilities	31.96	30.05	-	-	-	-
Total Liabilities	110.28	91.52	4.08	6.54	3.76	3.68
Common Stock	-	-	-	0	0	-
Additional Paid-In Capital	106.95	103.68	18.76	7.07	2.43	-
Retained Earnings	-75.03	-64.79	-21.48	-13.52	-6.14	-3.68
Total Common Equity	35.1	38.88	-2.71	-6.44	-3.71	-3.68
Shareholders' Equity	35.1	38.88	-2.71	-6.44	-3.71	-3.68
Total Liabilities & Equity	145.38	130.4	1.37	0.1	0.06	-
Total Debt	52.93	34.83	2.19	1.27	0.54	1.1
Net Cash (Debt)	-20.96	-16.86	-1.67	-1.17	-0.49	-1.1
Net Cash Per Share	-8.20	-8.96	-3.00	-9.18	-11.15	-
Filing Date Shares Outstanding	3.48	3.36	0.61	0.59	0.11	-
Total Common Shares Outstanding	3.37	3.23	0.61	0.39	0.11	-
Working Capital	44.8	27.42	-2.71	-6.44	-3.71	-2.58
Book Value Per Share	10.42	12.02	-4.45	-16.46	-33.36	-
Tangible Book Value	-28.02	-25.27	-2.71	-6.44	-3.71	-3.68
Tangible Book Value Per Share	-8.31	-7.81	-4.45	-16.46	-33.36	-
Machinery	-	1.96	-	-	-	-
Construction In Progress	-	1.51	-	-	-	-
Leasehold Improvements	-	5.97	-	-	-	-

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q